These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 307352)

  • 1. Intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease in Yugoslavia.
    Kozarevic D; Laban M; Budimir M; Vojvodic N; Roberts A; Gordon T; McGee DL
    Am Rev Respir Dis; 1978 Jun; 117(6):1039-43. PubMed ID: 307352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease.
    Shigeoka JW; Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Speers DM; Lin CC
    Am Rev Respir Dis; 1976 Dec; 114(6):1077-84. PubMed ID: 1087539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationships between serum chemotactic factor inactivator, alpha 1-antitrypsin deficiency, and chronic obstructive lung disease.
    Lam S; Chan-Yeung M; Abboud R; Kreutzer D
    Am Rev Respir Dis; 1980 Mar; 121(3):507-12. PubMed ID: 6968167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy.
    Cox DW; Hoeppner VH; Levison H
    Am Rev Respir Dis; 1976 May; 113(5):601-6. PubMed ID: 1083700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic obstructive pulmonary disease and alpha-1-antitrypsin (Pi) variation: a family study.
    Benjamin JJ; Cohen BH; Ball WC; Levy DA; Menkes HA; Kreiss P
    Birth Defects Orig Artic Ser; 1974; 10(4):212-6. PubMed ID: 4549777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease inhibitors in chronic obstructive pulmonary disease.
    Barnett TB; Gottovi D; Johnson AM
    Am Rev Respir Dis; 1975 May; 111(5):587-93. PubMed ID: 1079422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, epidemiologic, and pulmonary function studies in alpha,-antitrypsin-deficient subjects of Pi Z type.
    Rawlings W; Kreiss P; Levy D; Cohen B; Menkes H; Brashears S; Permutt S
    Am Rev Respir Dis; 1976 Nov; 114(5):945-53. PubMed ID: 1086622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 1-antitrypsin Pi-types in 965 COPD patients.
    Lieberman J; Winter B; Sastre A
    Chest; 1986 Mar; 89(3):370-3. PubMed ID: 3485034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.
    Silverman EK; Pierce JA; Province MA; Rao DC; Campbell EJ
    Ann Intern Med; 1989 Dec; 111(12):982-91. PubMed ID: 2596778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family study of the variability of pulmonary function in alpha 1-antitrypsin deficiency. Quantitative phenotypes.
    Silverman EK; Province MA; Rao DC; Pierce JA; Campbell EJ
    Am Rev Respir Dis; 1990 Nov; 142(5):1015-21. PubMed ID: 2240821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pi-Z phenotypes in a pulmonary clinic. Their prevalence and physiologic state.
    Gerblich AA; Kleinerman J; Rynbrandt DJ; Chester EH; Ihrig J
    Am J Clin Pathol; 1978 May; 69(5):509-13. PubMed ID: 306745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking and intermediate alpha1-antitrypsin deficiency and lung function in middle-aged men.
    Larsson C; Eriksson S; Dirksen H
    Br Med J; 1977 Oct; 2(6092):922-5. PubMed ID: 303135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of protease inhibitor phenotypes to obstructive lung diseases in a community.
    Morse JO; Lebowitz MD; Knudson RJ; Burrows B
    N Engl J Med; 1977 May; 296(21):1190-4. PubMed ID: 300842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological studies in a large sibship with antitrypsin deficiency.
    Duncan PE; Griffin JP
    Br J Dis Chest; 1975 Apr; 69(2):107-17. PubMed ID: 49190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygosity in the Pi-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD).
    Bartmann K; Fooke-Achterrath M; Koch G; Nagy I; Schütz I; Weis E; Zierski M
    Eur J Respir Dis; 1985 Apr; 66(4):284-96. PubMed ID: 3874784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits.
    Silverman EK; Province MA; Campbell EJ; Pierce JA; Rao DC
    Genet Epidemiol; 1992; 9(5):317-31. PubMed ID: 1427021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenotype Pi and alpha 1 antitrypsin deficiency in types A and B chronic obstructive bronchopneumopathies].
    Dyan A; Martin JP; Saint-Paul M; Baud F; Bignon J
    Pathol Biol (Paris); 1975 Sep; 23(7):525-33. PubMed ID: 1101155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A community study of the relation of alpha1-antitrypsin levels to obstructive lung diseases.
    Morse JO; Lebowitz MD; Knudson RJ; Burrows B
    N Engl J Med; 1975 Feb; 292(6):278-81. PubMed ID: 1078596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung function studies in asymptomatic individuals with moderately (Pi SZ) and severely (Pi Z) reduced levels of alpha1-antitrypsin.
    Larsson C; Dirksen H; Sundström G; Eriksson S
    Scand J Respir Dis; 1976; 57(6):267-80. PubMed ID: 1087749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 1-antitrypsin phenotypes and obstructive lung disease in the city of Oslo.
    Gulsvik A; Fagerhol MK
    Scand J Respir Dis; 1979 Oct; 60(5):267-74. PubMed ID: 316573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.